Quarterly report · Q1
6323.TEDINET S100U1U0
Period2024-03-01 → 2024-05-31
Filed2024-07-16
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.3bn | 2024-03-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥93.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Operating income | ¥8.7bn | 2024-03-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥4.7bn | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥11.4bn | 2024-03-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥27.1bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥11.4bn | 2024-03-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.2bn | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.8bn | 2024-03-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.6bn | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.9bn | 2024-03-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥3.7bn | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥161.8bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥156.1bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥141.6bn | at 2023-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥53.2bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥56.6bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥108.5bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥99.5bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥80.1bn | at 2023-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥40.2bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥38.0bn | at 2024-02-29 | Cons. | Cash and deposits |
| EPS (basic) | ¥498.18 | 2024-03-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,111.11 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.91 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥497.26 | 2024-03-01 → 2024-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1,109.06 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥201.54 | 2023-03-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 62.4% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.1% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-05-31 | −¥104m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-05-31 | −¥104m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-05-31 | −¥173m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥152m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥152m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | segment profit | 2024-03-01 → 2024-05-31 | −¥40m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥29.2bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥29.1bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥104m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥9.0bn |
| —segment total | revenue | 2024-03-01 → 2024-05-31 | ¥29.4bn |
| —segment total | revenue external | 2024-03-01 → 2024-05-31 | ¥29.3bn |
| —segment total | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥104m |
| —segment total | segment profit | 2024-03-01 → 2024-05-31 | ¥8.9bn |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥118m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥100m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥100m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | segment profit | 2023-03-01 → 2023-05-31 | −¥62m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥16.6bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥16.6bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥2m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥4.9bn |
| —segment total | revenue | 2023-03-01 → 2023-05-31 | ¥16.7bn |
| —segment total | revenue external | 2023-03-01 → 2023-05-31 | ¥16.7bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥2m |
| —segment total | segment profit | 2023-03-01 → 2023-05-31 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 356
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | Prior1YTDDuration | 5210000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 11362000000 | JPY |
| Income taxes current | Prior1YTDDuration | 1470000000 | JPY |
| Income taxes current | CurrentYTDDuration | 2732000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 37000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -270000000 | JPY |
| Income taxes | Prior1YTDDuration | 1507000000 | JPY |
| Income taxes | CurrentYTDDuration | 2462000000 | JPY |
| Profit loss | Prior1YTDDuration | 3702000000 | JPY |
| Profit loss | CurrentYTDDuration | 8899000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 145000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 125000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 3557000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 8774000000 | JPY |
| Profit loss | Prior1YTDDuration | 3702000000 | JPY |
| Profit loss | CurrentYTDDuration | 8899000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 15000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 69000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 148000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 2861000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 164000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 2931000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 3867000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 11830000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 3861000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 11553000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 5000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 277000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E02328-000SemiconductorAndFPDReportableSegmentsMember | 16592000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E02328-000LifeScienceReportableSegmentsMember | 100000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 16693000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 16693000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02328-000SemiconductorAndFPDReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02328-000SemiconductorAndFPDReportableSegmentsMember | 16595000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E02328-000LifeScienceReportableSegmentsMember | 100000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 16696000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Net sales | Prior1YTDDuration | 16693000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02328-000SemiconductorAndFPDReportableSegmentsMember | 4898000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E02328-000LifeScienceReportableSegmentsMember | -62000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 4836000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -118000000 | JPY |
| Operating income | Prior1YTDDuration | 4718000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02328-000SemiconductorAndFPDReportableSegmentsMember | 29135000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E02328-000LifeScienceReportableSegmentsMember | 152000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |